Enhabit First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Enhabit (NYSE:EHAB) First Quarter 2025 Results

Key Financial Results

• Revenue: US$259.9m (down 1.0% from 1Q 2024).
• Net income: US$17.8m (up by US$17.6m from 1Q 2024).
• Profit margin: 6.8% (up from 0.1% in 1Q 2024).
• EPS: US$0.35 (up from US$0.004 in 1Q 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Enhabit EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) exceeded analyst estimates significantly.

Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 28% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Enhabit's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.